Nup155 is linked to the p53 pathway in hepatocellular carcinoma

被引：0
|
作者：
Holzer, K. [1 ]
Ori, A. [2 ]
Winkler, J. [1 ]
Cooke, A. [2 ]
Eiteneuer, E. [1 ]
Beck, M. [2 ]
Schirmacher, P. [1 ]
Singer, S. [1 ]
机构：
[1] Heidelberg Univ, Inst Pathol, Heidelberg, Germany
[2] European Mol Biol Lab, D-69012 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50479-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
537
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [1] Nucleoporin Nup155 is part of the p53 network in liver cancer
    Holzer, Kerstin
    Ori, Alessandro
    Cooke, Amy
    Dauch, Daniel
    Drucker, Elisabeth
    Riemenschneider, Philip
    Andres-Pons, Amparo
    DiGuilio, Amanda L.
    Mackmull, Marie-Therese
    Bassler, Jochen
    Roessler, Stephanie
    Breuhahn, Kai
    Zender, Lars
    Glavy, Joseph S.
    Dombrowski, Frank
    Hurt, Ed
    Schirmacher, Peter
    Beck, Martin
    Singer, Stephan
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [2] Nucleoporin Nup155 is part of the p53 network in liver cancer
    Kerstin Holzer
    Alessandro Ori
    Amy Cooke
    Daniel Dauch
    Elisabeth Drucker
    Philip Riemenschneider
    Amparo Andres-Pons
    Amanda L. DiGuilio
    Marie-Therese Mackmull
    Jochen Baßler
    Stephanie Roessler
    Kai Breuhahn
    Lars Zender
    Joseph S. Glavy
    Frank Dombrowski
    Ed Hurt
    Peter Schirmacher
    Martin Beck
    Stephan Singer
    Nature Communications, 10
  • [3] Interaction of Nup53 with Ndc1 and Nup155 is required for nuclear pore complex assembly
    Eisenhardt, Nathalie
    Redolfi, Josef
    Antonin, Wolfram
    JOURNAL OF CELL SCIENCE, 2014, 127 (04) : 908 - 921
  • [4] The p53 family in hepatocellular carcinoma
    Kunst, Claudia
    Haderer, Marika
    Heckel, Sebastian
    Schlosser, Sophie
    Mueller, Martina
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 632 - 638
  • [5] P53 HOTSPOT MUTATION IN HEPATOCELLULAR-CARCINOMA IS LINKED TO AFLATOXIN EXPOSURE
    OZTURK, M
    BRESSAC, B
    PUISIEUX, A
    KEW, M
    VOLKMANN, M
    BOZCALI, S
    MURA, JB
    DELAMONTE, S
    CARLSON, R
    BLUM, H
    WANDS, J
    TAKAHASHI, H
    VONWEIZSACKER, F
    GALUN, E
    KAR, S
    CARR, B
    SCHRODER, C
    ERKEN, E
    VARINLI, S
    RUSTGI, V
    PRAT, J
    TODA, G
    KOCH, H
    LIANG, X
    TANG, Z
    SHOUVAL, D
    LEE, H
    VYAS, G
    SAROSI, I
    HEPATOLOGY, 1991, 14 (04) : A94 - A94
  • [6] FOCUSING IN ON P53 IN HEPATOCELLULAR-CARCINOMA
    CARBONE, D
    HEPATOLOGY, 1991, 14 (04) : 742 - 744
  • [7] Apoptosis, PCNA and p53 in hepatocellular carcinoma
    Paiva, C
    Oshima, CTF
    Lanzoni, VP
    Forones, NM
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 1058 - 1061
  • [8] Hepatocellular carcinoma and p53 gene therapy
    Fricker, J
    MOLECULAR MEDICINE TODAY, 1996, 2 (09): : 361 - 361
  • [9] p53 and gene therapy for hepatocellular carcinoma
    Habib, NA
    Mitry, RR
    Sadri, R
    GENE THERAPY OF CANCER, 1998, 451 : 499 - 504
  • [10] Hepatocellular Carcinoma and Chemotherapy: The Role of p53
    Brito, A. F.
    Abrantes, A. M.
    Pinto-Costa, C.
    Gomes, A. R.
    Mamede, A. C.
    Casalta-Lopes, J.
    Goncalves, A. C.
    Sarmento-Ribeiro, A. B.
    Tralhao, J. G.
    Botelho, M. F.
    CHEMOTHERAPY, 2012, 58 (05) : 381 - 386
12345